The dates and venue for the upcoming Hematology event will be announced shortly.
For further details, Please contact us at email@example.com or call + 1 (702) 988 2320.
Title: Next generation of drug delivery system: stimuli-sensitive combination nanopreparations.
Title: Nanoparticle Delivery of Mitochondria-Associated MicroRNA Regulating Inflammation in the Central Nervous System.
Title: Engineered spatiotemporal delivery of morphogens for skeletal regeneration.
Title: Drug screening and targeting against the stem subpopulation of cancer cells.
Title: Peptide delivery to the brain: A novel treatment for migraine.
Title: Overcoming the barriers to effective targeted drug delivery through stem cell-derived Nano-Ghosts.
Title: Physicochemical characterization of co-crystals and cyclodextrin inclusion complexes of bioactive molecules.
Title: Signaling peptides for brain diseases: Delivery and action.
Title: Impact of inhalation manoeuvre parameters on drug delivery to the Lungs from dry powder inhalers in-vitro and Ex-vivo.
Title: Poly (vinyl pyrrolidone) Nanofibers as Drug Delivery of Sildenafil Citrate.
Title: Understanding the Impact of Nanoparticle Structure on Cellular Response.
Title: 5-Tiered (pre-) formulation approach to support toxicology studies.
Title: Challenges of in vitro drug release testing from advanced mucosal formulations.
Title: Chimeric and Multicompartment Drug Delivery Systems: Lessons learned and future perspectives.
Title: Lipid based parenteral depots for biomolecules, an update on recent work.
Title: Computational blind docking of ligands to drug targets: methodology and applications.
Title: The influence of gut microbiota-mediated bile acid metabolism on the cellular response to therapeutics at the intestinal barrier.
Title: Cyclodextrin-based photoactive liposomal nanoparticles for tumor targeting.
Title: Getting health allies from agriculture enemies: plant viruses as smart nanoparticles for vaccine/drug delivery.
Title: New aerosol treatment for human nasal cavity through numerical simulation.
Title: Porous biodegradable particles for efficient transfollicular drug delivery.
Title: Polyethyleneimine-simvastatin nanoparticles loaded PANi/chitosan-gelatin scaffolds as drug delivery for osteogenesis.
Title: Case presentation: Patient with metastatic pancreatic adenocarcinoma treated with nanoliposomal irinotecan combination therapy.
Title: Polyethylenimine-based nanoparticles decorated with small molecules mimicking RGD peptide for targeted plasmid DNA delivery.
Title: Brain targeted nanotherapeutics: an enticing journey from ideation to product realization.
Title: Cyclic GMP-AMP: A new hope for metabolic disease?
Title: Characterization of lactose carrier for dry powder inhaler formulations.
Title: Casein-based nanovehicles for oral delivery of chemotherapeutic combinations to overcome multidrug resistance in gastric cancer.
Title: Delivery of siRNA in vivo to the liver using redox sensitive and ionizable lipids.
Title: The Competitive binding Studies of CMP Inhibitor and Polysialic Acid (polySia) to the Polybasic Polysialyltransferase Domain (PSTD) in the Polysialyltransferase.
Title: New potential nanotechnology-based therapy with novel Gal-3 inhibitor for the treatment of rheumatoid arthritis.
Title: The effects of drug encapsulation into gellan gum matrix by the example of roxithromycin, naproxen and meloxicam.
Title: Active loading of resveratrol in transferrin-functionalised liposomes using a pH gradient technique.
Title: Myometrium-targeted liposomes for prevention of preterm labor.
Title: Use of an inflating agent to engineer novel lactose carrier for inhalation and drug deposition in-vitro using three model drugs: salbutamol, beclomethasone and fluticasone.
Title: Novel RNA-carbohydrate conjugates for modulation of LDLR and cholesterol by transcriptional silencing.
Title: Synthesis and cytotoxicity studies on novel piperazinylacetamides.
Title: HEA-HEMA hydrogels: Composition effect on physicochemical and pharmaceutical properties.
Title: Targeting nanomedicine to the vascular endothelium.
Title: EAAT3 proteins as a pharmacological target for the design of new antiepileptic drugs.
Title: Microbiological pharmaceutical analysis: Better safe than sorry.